Karachi: Ferozsons Laboratories Limited has scheduled a board meeting for October 28, 2024, at its Rawalpindi office, aiming to discuss the quarterly financial results ending September 30, 2024. The meeting is critical for declaring any shareholder entitlements.

The company has entered a closed period from October 1, 2024, to October 28, 2024, following the Pakistan Stock Exchange (PSX) regulations, which prohibits all directors and executive members from buying or selling company shares during this time. This measure ensures the prevention of insider trading and upholds the integrity of financial disclosures.

Shareholders and TRE Certificate Holders have been advised of the closed period, and the company will disclose the results and any potential entitlements at the conclusion of the board meeting. According to information available from the Pakistan Stock Exchange (PSX), such regulations are designed to maintain transparency and fairness in the trading of company shares.

Ferozsons Laboratories, a major player in the pharmaceutical industry, has not disclosed the specific details of the financial results expected to be released. This upcoming declaration is pivotal for investors tracking the performance and future outlook of the company.